Thursday, 19 November 2026 | Asia's First Monthly Magazine on e-Governance · Est. 2005
SAS Digital Sovereignty
Gujarat AI Summit
SAS Digital Sovereignty
Gujarat AI Summit
Live — 2,069 transfers tracked Updated 18-11-2026, 14:46
Live
Deputation J&K transfers JKAS officer Sabha Sarwar on deputation to Ladakh Today Transfer Maharashtra reshuffles three senior IAS officers across Mantralaya departments Today Transfer Uttarakhand reshuffles six IAS officers, Nitesh Kumar Jha named Secretary Urban Development Today Appointment Malay Jain Named Balaghat SP in Madhya Pradesh IPS 6d ago Appointment Ajay Kumar Yadav Appointed CRPF Additional Director General 10d ago Promotion Punjab Elevates Four Senior IPS Officers to DGP Rank 11d ago Appointment K. Lakshmipriya Named GBA Special Commissioner, Karnataka 12d ago Transfer Bihar Home Department transfers Khagaria SP Bhanu Pratap Singh to Police Headquarters 13d ago Transfer Jharkhand transfers seven IAS officers, Anup Garg named Joint Secretary in Building Construction 13d ago Appointment Girish S.N. Named Odisha Health Commissioner-Secretary 14d ago Extension Maharashtra reshuffles 16 police officers, three Thane seniors get one-year extension 14d ago Posting Shailendra Kumar gets interim charge of J&K Chief Secretary post 14d ago Transfer Uttar Pradesh transfers two IPS officers across Noida and Kanpur Nagar commissionerates 15d ago Resignation Madhya Pradesh IPS officer Anurag Sujania resigns four days after transfer from Sagar 15d ago Transfer Tamil Nadu transfers three central prison superintendents amid escape incidents 15d ago Transfer Bihar Reshuffles Four Senior IAS Officers Across Key Departments 15d ago Posting 1991-Batch IAS Officer CK Anil Takes Charge as Bihar Education ACS 15d ago Transfer Odisha IPS Reshuffle: Jail DG Sushant Nath Moved to Home Department as OSD 15d ago Transfer J&K Reshuffles 12 IAS, IPS and JKAS Officers Across Key Departments 16d ago Transfer UP IAS Reshuffle: Alok Kumar-II Becomes IIDC, 15 Officers Moved 16d ago Transfer Kerala Reshuffles 35 IAS Officers, Jyothilal Gets Home Department 16d ago Transfer Karnataka Transfers 9 Officers; Latha R. Appointed Housing Board Commissioner 30d ago Transfer UP Transfers 7 IAS Officers; Dhirendra Singh Sachan Gets Panchayati Raj Charge 30d ago Transfer Delhi Assigns New Roles to 3 IAS Officers; Nandini Paliwal Gets Power Department 30d ago Transfer MP Transfers 4 IAS Officers; Ramprakash Ahirwar Gets Bhopal Municipal Commissioner Post 19 Oct Transfer Andhra Pradesh Transfers 11 IAS Officers; B. Anil Kumar Reddy Gets Industries Post 13 Oct Appointment Centre Approves 26 Senior Appointments; Manisha Trighatia Gets Urban Development Role 12 Oct Transfer J&K Transfers 49 IAS, JKAS Officers; Mamta Yadav Gets Information Department 12 Oct Transfer Chhattisgarh Transfers 18 IPS Officers; Jha Amankumar Ramankumar Gets SIA Charge 10 Oct Transfer Delhi Transfers 34 IAS, DANICS Officers; Awanish Kumar Gets Excise Charge 9 Oct

Hover a headline to pause it · drag the rail to scrub · ← → to step · Space to pause

Home · News

DST supports Seagull BioSolutions for preparing asymptomatic COVID-19 kits and vaccinces

Seagull BioSolutions, a startup working on new biological technologies, is being funded by the Department of Science & Technology (DST), to undertake the development of Active Virosome (AV)-Vaccine and Immunodiagnostic kits for COVID-19 emergency.


Active Virosome Technology (AVT) developed by Seagull Bio is useful for the production of vaccines & immunotherapeutic agents. The AVT platform is useful for producing novel, non-hazardous & economical Active Virosome agents expressing desired antigens from the target pathogen. These will be used to develop a novel vaccine for the prevention of COVID-19 infection and also immunodiagnostic ELISA kits for COVID-19.

‘Accurate diagnostics, breaking the chain of transmission, therapy and preventive measures including safe and effective vaccines are the foundational pillars of addressing the challenges of COVID-19. Of these, developing vaccines has the longest timeline and so it is essential to fast track that activity NOW”, said Prof Ashutosh Sharma, Secretary, DST.


Polymerase chain reaction (PCR)-based diagnostic kits which are currently available in India are rapid & enable detection of active COVID-19 infection but cannot identify asymptomatic infections or those people who were exposed to or infected with COVID-19 in the past and did not suffer from the disease or have recovered from COVID-19 disease and may still be spreading the virus. In contrast, Immunodiagnostic kits help in detection of antibodies to COVID which can identify these infections also. Therefore, SBPL has initiated efforts to produce Immunodiagnostic kits for COVID-19. These tests will enable healthcare researchers to monitor the spread of COVID-19 more accurately.


Seagull Biobased out of Entrepreneurship Development Center (Venture Center), Pune, and supported under Seed Support System of the Technology Development Board (TDB), DST is

producing two types of Active Virosome (AV) agents. SBPL will produce two types of AV agents – one expressing S protein of COVID-19 (AV-S) and another one expressing structural


proteins of COVID-19 (AV-SPs). SBPL is currently amplifying the synthesis of both these agents up to 10 mg levels so that their immunogenicity can be tested. This test will first be

performed in wild type mice to ascertain the ability of AV-S & AV-SPs to induce anti-COVID19 neutralizing antibodies & cellular immune response(s).

Once this is proven, they will undertake efficacy studies in ACE-2R+ mice, which are used as a model for SARS disease. In parallel, a bioprocess for production of AV- agent will be

established & the AV-agent produced in large scale about 100,000 vaccine doses. Detailed toxicity, safety & pharmacokinetic study will be performed in ACE2R+ mice and another small animal species or Monkeys, and then the AV-vaccine agent will be prepared for Phase I clinical trials. The company anticipates that the unique features of AVs will enable starting Phase I trials by the end of 18-20 months.

In parallel to this Vaccine project, SBPL will also use the Active Virosomes expressing S protein of COVID-19 as an antigen for developing immunodiagnostic kits. IgM captures ELISA kits, IgG type antibody detecting ELISA kits, and a Lateral flow (LFA) immunodiagnostic test will be produced. LFA tests will empower individual citizens of India to test themselves easily & ensure that they remain disease-free.

SBPL expects the Immunodiagnostic kits to be ready for field trials by the end of Aug 2020 and approved by the end of 10-11 months. On the other hand, the AV vaccine is expected to take a longer time. However, given the emergency situation, SBPL aims to complete the proof of concept in 80 days & complete preclinical development & start Phase I trial by the end of 18-20 months.

EN
Written by

Elets News Network

Elets News Network reports on governance, public policy and digital government across India.

IAS Transfer Tracker

Live — 2,069 transfers tracked Updated 18-11-2026, 14:46

The eGov Weekly Briefing

A weekly round-up of governance news, interviews and policy analysis — in your inbox.